Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Abstract
OBJECTIVE: To identify the adherence value cut-off point that optimally stratifies good versus poor compliers using administratively derived adherence measures, the medication possession ratio (MPR) and the proportion of days covered (PDC) using hospitalization episode as the primary outcome among Medicaid eligible persons diagnosed with schizophrenia, diabetes, hypertension, congestive heart failure (CHF), or hyperlipidemia. RESEARCH DESIGN AND METHODS: This was a retrospective analysis of Arkansas Medicaid administrative claims data. Patients > or =18 years old had to have at least one ICD-9-CM code for the study diseases during the recruitment period July 2000 through April 2004 and be continuously eligible for 6 months prior and 24 months after their first prescription for the target condition. Adherence rates to disease-specific drug therapy were assessed during 1 year using MPR and PDC. MAIN OUTCOME MEASURE AND ANALYSIS SCHEME: The primary outcome measure was any-cause and disease-related hospitalization. Univariate logistic regression models were used to predict hospitalizations. The optimum adherence value was based on the adherence value that corresponded to the upper most left point of the ROC curve corresponding to the maximum specificity and sensitivity. RESULTS: The optimal cut-off adherence value for the MPR and PDC in predicting any-cause hospitalization varied between 0.63 and 0.89 across the five cohorts. In predicting disease-specific hospitalization across the five cohorts, the optimal cut-off adherence values ranged from 0.58 to 0.85. CONCLUSIONS: This study provided an initial empirical basis for selecting 0.80 as a reasonable cut-off point that stratifies adherent and non-adherent patients based on predicting subsequent hospitalization across several highly prevalent chronic diseases. This cut-off point has been widely used in previous research and our findings suggest that it may be valid in these conditions; it is based on a single outcome measure, and additional research using these methods to identify adherence thresholds using other outcome metrics such as laboratory or physiologic measures, which may be more strongly related to adherence, is warranted.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A cut-off for optimal adherence of PDC equal to or higher than 80% is reasonable for predictable hospitalizations in chronic diseases.
“Cut-off for optimal adherence was defined as PDC equal or higher than 80% as this has been found to be reasonable for predictable hospitalizations in chronic diseases”
From Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy (2019) · cites this paper as Karve et al., 2009
Cites
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,906 · see citing works
Applied Linear Statistical Models
Kutner, M., Nachtsheim, C. J., Neter, J., & Li, W. (1997) · Technometrics · doi:10.1080/00401706.1997.10485141 · Cited by 7,186 · see citing works
Applied Linear Statistical Models.
Lorenz, F. O., Neter, J., Wasserman, W., & Kutner, M. (1986) · Journal of the American Statistical Association · doi:10.2307/2289108 · Cited by 5,566 · see citing works
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · see citing works
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729 · see citing works
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232 · see citing works
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,198 · see citing works
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135 · see citing works
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 759 · see citing works
Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve
Cook, N. R. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.096529 · Cited by 691 · see citing works
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F. H., & Nichol, M. B. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00139.x · Cited by 638 · see citing works
Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.886 · Cited by 621 · see citing works
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603 · see citing works
Bramley, T. J., Nightengale, B. S., Frech-Tamas, F., & Gerbino, P. P. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.3.239 · Cited by 380 · see citing works
The association between diabetes metabolic control and drug adherence in an indigent population
Schectman, J. M., Nadkarni, M. M., & Voss, J. D. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1015 · Cited by 373 · see citing works
Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission
Valenstein, M. M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., Bingham, C. R., & Stavenger, T. (2002) · Medical Care · doi:10.1097/00005650-200208000-00002 · Cited by 339 · see citing works
Lau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 317 · see citing works
Martin, B. C., Wiley-Exley, E. K., Richards, S., Domino, M. E., Carey, T. S., & Sleath, B. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1k671 · Cited by 226 · see citing works
Self-citationMixture models for cancer survival analysis: application to population-based data with covariates
Angelis, R. D., Capocaccia, R., Hakulinen, T. R., Söderman, B., & Verdecchia, A. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990228)18:4 · Cited by 207 · see citing works
The Language of Medication-Taking
Steiner, J. F., & Earnest, M. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-11-200006060-00026 · Cited by 190 · see citing works
Validity of a Prescription Claims Database to Estimate Medication Adherence in Older Persons
Grymonpre, R., Cheang, M., Fraser, M., Metge, C. J., & SITAR, D. S. (2006) · Medical Care · doi:10.1097/01.mlr.0000207817.32496.cb · Cited by 187 · see citing works
Karve, S. J., Cleves, M. A., Helm, M. E., Hudson, T. J., West, D. S., & Martin, B. C. (2008) · Medical Care · doi:10.1097/mlr.0b013e31817924d2 · Cited by 176 · see citing works
Self-citationParris, E. S., Lawrence, D. B., Mohn, L. A., & Long, L. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.595 · Cited by 155 · see citing works
Karve, S. J., Cleves, M. A., Helm, M. E., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00543.x · Cited by 132 · see citing works
Self-citationHypertension management: the care gap between clinical guidelines and clinical practice.
Andrade, S. E., Gurwitz, J. H., Field, T. S., Kelleher, M., Majumdar, S. R., Reed, G. W., & Black, R. S. (2004) · PubMed · Cited by 114 · see citing works
Pioglitazone initiation and subsequent hospitalization for congestive heart failure
Karter, A., Ahmed, A., Liu, J., Moffet, H. M., & Parker, M. M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01704.x · Cited by 90 · see citing works
Benner, J. S., Pollack, M. F., Smith, T. W., Bullano, M. F., Willey, V. J., & Williams, S. A. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040419 · Cited by 70 · see citing works
Stroupe, K. T., Teal, E., Tu, W., Weiner, M., & Murray, M. D. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.6.779 · Cited by 48 · see citing works
Kalsekar, I. D., Madhavan, S., Amonkar, M. M., Douglas, S. M., Makela, E. H., Elswick, B. M., & Scott, V. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.02.005 · Cited by 37 · see citing works
Woltmann, E. M., Valenstein, M. M., Welsh, D. E., Lee, T. A., Wolschon, P. A., Grabowski, J. G., & Reilly, P. A. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.864 · Cited by 31 · see citing works
Hospitalization Risks in the Treatment of Schizophrenia
Gianfrancesco, F. D., Rajagopalan, K., & Wang, R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000231536.79175.cd · Cited by 15 · see citing works
Kalsekar, I. D., Iyer, S. S., Mody, R., et al. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.2.121 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870 · see citing works
Vervloet, M., Linn, A. J., van Weert, J. C. M., de Bakker, D. H., Bouvy, M. L., & van Dijk, L. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000748 · Cited by 455 · see citing works
Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
Kirkman, M. S., Rowan-Martin, M. T., Levin, R., Fonseca, V. A., Schmittdiel, J. A., Herman, W. H., & Aubert, R. E. (2015) · Diabetes Care · doi:10.2337/dc14-2098 · Cited by 388 · see citing works
The myths of medication adherence
Gellad, W. F., Thorpe, C. T., Steiner, J. F., & Voils, C. I. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4334 · Cited by 98 · see citing works
Keyloun, K. R., Hansen, R. N., Hepp, Z., Gillard, P., Thase, M. E., & Devine, E. B. (2017) · CNS Drugs · doi:10.1007/s40263-017-0417-0 · Cited by 99 · see citing works
Jenkins-Jones, S., Parviainen, L., Porter, J., Withe, M., Whitaker, M. J., Holden, S. E., Morgan, C. L., Currie, C. J., & Ross, R. J. M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0895 · Cited by 85 · see citing works
How to Screen for Non-Adherence to Antihypertensive Therapy
Gupta, P., Patel, P., Horne, R., Buchanan, H., Williams, B., & Tomaszewski, M. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0697-7 · Cited by 84 · see citing works
Adherence and persistence rates of major antidiabetic medications: a review
Lee, D. S. U., & Lee, H. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00785-1 · Cited by 72 · see citing works
Hansen, R. A., Farley, J. F., Droege, M., & Maciejewski, M. L. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.011 · Cited by 68 · see citing works
Medication adherence and resistant hypertension
Hyman, D. J., & Pavlik, V (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.73 · Cited by 61 · see citing works
Barai, N., Monroe, A., Lesko, C., Lau, B., Hutton, H., Yang, C., Alvanzo, A., McCaul, M. E., & Chander, G. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1580-x · Cited by 53 · see citing works
Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy
Torres-Robles, A., Wiecek, E., Cutler, R., Drake, B., Benrimoj, S. I., Fernandez-Llimos, F., & Garcia-Cardenas, V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00130 · Cited by 33 · see citing works
Lim, C.-E., Pasternak, B., Eliasson, B., & Ueda, P. (2025) · Diabetologia · doi:10.1007/s00125-025-06439-x · Cited by 27 · see citing works
Hoo, Z. H., Boote, J., Wildman, M. J., Campbell, M. J., & Gardner, B. (2017) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2017.1338958 · Cited by 21 · see citing works
Lim, D., & Woo, K. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.11.014 · Cited by 8 · see citing works
Dong, X., Tsang, C. C. S., Wan, J. Y., Chisholm-Burns, M. A., Finch, C. K., Tsao, J. W., Browning, J. A., Garuccio, J., Zeng, R., & Wang, J. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100420 · Cited by 1 · see citing works
- Authors
- Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C.
- Affiliations
- The Ohio State University (US)
- University of Arkansas for Medical Sciences (US)
- University of Mississippi (US)
- Corresponding author
- Karve, Sudeep
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa UK Limited
- Published
- 2009-07-28
- Volume
- 25
- Issue
- 9
- Pages
- 2303-2310
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2102368961
- Cited by
- 620
- References
- 32
- Citations by year
- 2026: 32 · 2025: 44 · 2024: 36 · 2023: 43 · 2022: 53 · 2021: 68 · 2020: 44 · 2019: 45 · 2018: 43 · 2017: 43 · 2016: 35 · 2015: 30 · 2014: 32 · 2013: 27 · 2012: 19
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medical Research and Opinion (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- medication adherence, medication possession ratio, proportion of days covered, hospitalization, Medicaid, schizophrenia, diabetes mellitus, hypertension, congestive heart failure, hyperlipidemia, chronic disease, administrative claims data, ROC curve
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Arkansas, Calibration, Forecasting, Hospitalization, Humans, Insurance Claim Review, Medicaid, Middle Aged, Patient Compliance, Reference Values, Retrospective Studies, United States, Drug Monitoring, Health Care Costs, International Classification of Diseases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review